Mimedx (MDXG) EPS (Basic) Growth (3y) (2014 - 2026)
Powered by 
Analysis
Mimedx (MDXG) EPS (Basic) Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 24.18% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 24.57% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 19.63% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 50.64% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -6.23% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 29.56% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 17.98% |
| 10 | Mimedx | 665.96 Mn | 530.12 Mn | 44.38 Mn | -52.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -52.50% |
| Mar 31, 2026 | -32.16% |
| Dec 31, 2025 | 12.58% |
| Sep 30, 2025 | 48.45% |
| Jun 30, 2025 | 37.29% |
| Mar 31, 2025 | 34.64% |
| Dec 31, 2024 | 81.66% |
| Sep 30, 2024 | 52.07% |
| Jun 30, 2024 | 81.98% |
| Mar 31, 2024 | 39.03% |
| Dec 31, 2023 | 62.70% |
| Sep 30, 2023 | 28.60% |
| Jun 30, 2023 | 41.43% |
| Mar 31, 2023 | 10.91% |
| Dec 31, 2022 | 44.71% |
| Sep 30, 2022 | -40.45% |
| Jun 30, 2022 | 11.72% |
| Mar 31, 2022 | 4.63% |
| Dec 31, 2021 | 66.70% |
| Sep 30, 2021 | -176.04% |